Skip to main content
Right Decisions for Health and Care
Right Decisions for Health and Care
Search for toolkits, guidelines and other information:
Search 'Central Nervous System'...
Menu
All resources
Organisations
Learning & support
How to deliver RDS tools
Feedback
Right Decisions
Shared content
Back
GGC - Clinical guidelines
Musculoskeletal
Announcements and latest updates
test announcement
Musculoskeletal
Aqueous Phenol (use of 6%) in Unlicensed Indications in Pathological Muscle Hypertonia (611)
Botulinum toxin A in unlicensed indications in Pathological Muscle Hypertonia, (use of) (614)
Post Stroke Spasticity Service Use of Botulinum Toxin A (980)
Back to the top
